Posted on March 31, 2008 at 2:38 PM
Filed under: Trends
Tagged: acquisition , consolidation , Corporate Dealmaker , healthcare , IT , Ken Klee , Merger , technology

[ Share ]  [ E-mail ]  [ Leave a Comment ]

The Deal's Mary Kathleen Flynn sits down with Ken Klee, editor of Corporate Dealmaker, at The Healthcare Dealmaking Symposium to discuss how the turmoil in the financial markets is affecting deals within the healthcare market. In this clip, Klee talks about the narrowing of the IPO window around biotechs, M&A activity and integration challenges in the healthcare IT space, and the current restructuring of Big Pharma such as Pfizer Inc. and Bristol-Myers Squibb Co. - Maria Woehr



Goldman's Ken Hitchner on healthcare M&A
Healthcare symposium insights: Dance of the pharma-biotech dealmakers
The Deal's Healthcare Dealmaking Symposium: Licensing Deals
The Deal's Healthcare Dealmaking Symposium: Corporate Dealmaker's Panel

Join Corporate Dealmaker's LinkedIn forum

Also From Corporate Dealmaker

• Dell drives in IT services as PC slump deepens
• Proxy prelim: CF wins Terra board seats
• Deal Economy 2010: Avaya's Ali on digesting Nortel
• Disney, Microsoft, Abbott Labs win M&A awards
• Car czar says GM IPO could happen in 2010

Corporate Dealmaker Home Page

From TheDeal.com

• Hershey cleared to dine on Cadbury
• Deal Stocks: GS, DELL, CBY, HSY, GE, CMCSA
• GSI Group goes under
• Should MetroPCS take a Leap?
• The Deal Economy 2010: Avaya's Ali on digesting Nortel

TheDeal.com Home

Post a comment

Name:

Email Address:

URL:

Remember personal info?

Comments: (you may use HTML tags for style)

Please only click "Post" once. It may take a few moments to process.